Onyx Biotec is set to launch an IPO as a book-built issue worth Rs 29.34 crores, consisting entirely of a fresh issue of 48.1 lakh shares.
The IPO opens for subscription on November 13, 2024, and will close on November 18, 2024. The allotment of shares is scheduled to be finalized by Tuesday, November 19, 2024, and Onyx Biotec shares are expected to list on the NSE SME, with a tentative listing date set for Thursday, November 21, 2024.
Onyx Biotec operates in the pharmaceutical sector. They specialize in manufacturing sterile pharmaceutical products, including sterile water for injections, dry powder injections, and dry syrups. They serve both the Indian and international markets, supplying major pharmaceutical companies.
The price band for the IPO is set between ₹58 and ₹61 per share, with a minimum application lot size of 2,000 shares. Retail investors are required to invest a minimum of ₹122,000. For HNI investors, the minimum investment is 2 lots (4,000 shares), amounting to ₹244,000.
Horizon Management Private Limited is the book-running lead manager for the Onyx Biotec IPO, while Mas Services Limited serves as the registrar. The market maker for this IPO is Giriraj Stock Broking.
Onyx Biotec IPO Details:
| Company Name | Onyx Biotec Limited |
| Sector | Pharmaceutical |
| IPO Type | SME |
| IPO Open date | 13th Nov 2024 |
| IPO Close date | 18th Nov 2024 |
| OFS | |
| Listing Exchanges | NSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Onyx Biotec IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 2000 | 1,22,000 |
| HNI (Min) | 2 | 4000 | 2,44,000 |
Onyx Biotec IPO Timeline:
| IPO Open Date | 13th Nov 2024 |
| IPO Close Date | 18th Nov 2024 |
| Basis of Allotment | 19th Nov 2024 |
| Refund Initiation Date | 20th Nov 2024 |
| Shares Credit to Demat | 20th Nov 2024 |
| Listing Date | 21st Nov 2024 |
Things to Consider before applying for an IPO
Financial Performance: Review Onyx Biotec’s Financials to understand its revenue, profitability, and growth prospects.
Industry Outlook: Consider the overall health of India’s Pharmaceutical Industry.
Valuation: Compare the price band to similar companies in the industry to see if the IPO is priced fairly.
Management Team: Research the experience and capabilities of the management team.
Our Verdict
This IPO offers a good opportunity to invest in Onyx Biotec and be a part of its growth.
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
